These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Clinical value of NPHS2 analysis in early- and adult-onset steroid-resistant nephrotic syndrome. Santín S; Tazón-Vega B; Silva I; Cobo MÁ; Giménez I; Ruíz P; García-Maset R; Ballarín J; Torra R; Ars E; Clin J Am Soc Nephrol; 2011 Feb; 6(2):344-54. PubMed ID: 20947785 [TBL] [Abstract][Full Text] [Related]
4. Recessive NPHS2 (Podocin) mutations are rare in adult-onset idiopathic focal segmental glomerulosclerosis. He N; Zahirieh A; Mei Y; Lee B; Senthilnathan S; Wong B; Mucha B; Hildebrandt F; Cole DE; Cattran D; Pei Y Clin J Am Soc Nephrol; 2007 Jan; 2(1):31-7. PubMed ID: 17699384 [TBL] [Abstract][Full Text] [Related]
5. Molecular analysis of NPHS2 and ACTN4 genes in a series of 33 Italian patients affected by adult-onset nonfamilial focal segmental glomerulosclerosis. Aucella F; De Bonis P; Gatta G; Muscarella LA; Vigilante M; di Giorgio G; D'Errico M; Zelante L; Stallone C; Bisceglia L Nephron Clin Pract; 2005; 99(2):c31-6. PubMed ID: 15627790 [TBL] [Abstract][Full Text] [Related]
6. Clinical and epidemiological assessment of steroid-resistant nephrotic syndrome associated with the NPHS2 R229Q variant. Machuca E; Hummel A; Nevo F; Dantal J; Martinez F; Al-Sabban E; Baudouin V; Abel L; Grünfeld JP; Antignac C Kidney Int; 2009 Apr; 75(7):727-35. PubMed ID: 19145239 [TBL] [Abstract][Full Text] [Related]
7. The p.R229Q variant of the NPHS2 (podocin) gene in focal segmental glomerulosclerosis and steroid-resistant nephrotic syndrome: a meta-analysis. Lu L; Wan H; Yin Y; Feng WJ; Wang M; Zou YC; Huang B; Wang DT; Shi Y; Zhao Y; Wei LB Int Urol Nephrol; 2014 Jul; 46(7):1383-93. PubMed ID: 24715228 [TBL] [Abstract][Full Text] [Related]
8. Co-Inheritance of Functional Podocin Variants with Heterozygous Collagen IV Mutations Predisposes to Renal Failure. Stefanou C; Pieri M; Savva I; Georgiou G; Pierides A; Voskarides K; Deltas C Nephron; 2015; 130(3):200-12. PubMed ID: 26138234 [TBL] [Abstract][Full Text] [Related]
9. NPHS2 homozygous p.R229Q variant: potential modifier instead of causal effect in focal segmental glomerulosclerosis. Kerti A; Csohány R; Wagner L; Jávorszky E; Maka E; Tory K Pediatr Nephrol; 2013 Oct; 28(10):2061-4. PubMed ID: 23800802 [TBL] [Abstract][Full Text] [Related]
10. Genetic basis of nephrotic syndrome--review. Obeidová H; Merta M; Reiterová J; Maixnerová D; Stekrová J; Rysavá R; Tesar V Prague Med Rep; 2006; 107(1):5-16. PubMed ID: 16752799 [TBL] [Abstract][Full Text] [Related]
11. NPHS2 gene, nephrotic syndrome and focal segmental glomerulosclerosis: a HuGE review. Franceschini N; North KE; Kopp JB; McKenzie L; Winkler C Genet Med; 2006 Feb; 8(2):63-75. PubMed ID: 16481888 [TBL] [Abstract][Full Text] [Related]
12. R229Q polymorphism of NPHS2 gene in patients with late-onset steroid-resistance nephrotic syndrome: a preliminary study. Fotouhi N; Ardalan M; Jabbarpour Bonyadi M; Abdolmohammadi R; Kamalifar A; Nasri H; Einollahi B Iran J Kidney Dis; 2013 Sep; 7(5):399-403. PubMed ID: 24072153 [TBL] [Abstract][Full Text] [Related]
13. Podocyte-associated gene mutation screening in a heterogeneous cohort of patients with sporadic focal segmental glomerulosclerosis. Laurin LP; Lu M; Mottl AK; Blyth ER; Poulton CJ; Weck KE Nephrol Dial Transplant; 2014 Nov; 29(11):2062-9. PubMed ID: 24500309 [TBL] [Abstract][Full Text] [Related]
15. Mutations in podocyte genes are a rare cause of primary FSGS associated with ESRD in adult patients. Büscher AK; Konrad M; Nagel M; Witzke O; Kribben A; Hoyer PF; Weber S Clin Nephrol; 2012 Jul; 78(1):47-53. PubMed ID: 22732337 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of the de Almeida R; da Silva WC; Garbin HI; Itaquy TP; Dos Santos Pereira F; Garcia CD; Keitel E; Sales Luiz Vianna F; Veronese FV Clin Nephrol; 2020 Oct; 94(4):187-196. PubMed ID: 32691731 [TBL] [Abstract][Full Text] [Related]
17. Bigenic heterozygosity and the development of steroid-resistant focal segmental glomerulosclerosis. Löwik M; Levtchenko E; Westra D; Groenen P; Steenbergen E; Weening J; Lilien M; Monnens L; van den Heuvel L Nephrol Dial Transplant; 2008 Oct; 23(10):3146-51. PubMed ID: 18443213 [TBL] [Abstract][Full Text] [Related]
18. The mutation-dependent pathogenicity of NPHS2 p.R229Q: A guide for clinical assessment. Mikó Á; K Menyhárd D; Kaposi A; Antignac C; Tory K Hum Mutat; 2018 Dec; 39(12):1854-1860. PubMed ID: 30260545 [TBL] [Abstract][Full Text] [Related]
19. Broadening the spectrum of diseases related to podocin mutations. Caridi G; Bertelli R; Di Duca M; Dagnino M; Emma F; Onetti Muda A; Scolari F; Miglietti N; Mazzucco G; Murer L; Carrea A; Massella L; Rizzoni G; Perfumo F; Ghiggeri GM J Am Soc Nephrol; 2003 May; 14(5):1278-86. PubMed ID: 12707396 [TBL] [Abstract][Full Text] [Related]
20. Prevalence, genetics, and clinical features of patients carrying podocin mutations in steroid-resistant nonfamilial focal segmental glomerulosclerosis. Caridi G; Bertelli R; Carrea A; Di Duca M; Catarsi P; Artero M; Carraro M; Zennaro C; Candiano G; Musante L; Seri M; Ginevri F; Perfumo F; Ghiggeri GM J Am Soc Nephrol; 2001 Dec; 12(12):2742-2746. PubMed ID: 11729243 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]